KILL Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units

Rhea-AI Summary

Miller Thomson LLP has requested the cancellation of their press release regarding a C$10 million bought deal offering by Mydecine Innovations Group. The request indicates that the press release was disseminated without the company's authorization, raising concerns about proper communication protocols.

Positive

• None.

Negative

• Press release issued without prior authorization from Mydecine Innovations Group.

Miller Thomson LLP requests that their press release NewsItemId: 20210120005542 “Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units” be killed.

The release was issued by Miller Thomson LLP without prior authorization from Mydecine Innovations Group.

FAQ

What happened with Mydecine Innovations Group's C$10 million offering?

Miller Thomson LLP has requested the cancellation of a press release regarding a C$10 million bought deal offering for Mydecine Innovations Group.

Why was the press release about Mydecine Innovations Group recalled?

The recall was initiated because the release was issued without the prior authorization of Mydecine Innovations Group.

Who issued the press release about Mydecine Innovations Group's offering?

The press release was issued by Miller Thomson LLP.